Department of Reconstructive Dentistry, Faculty of Odontology, University of Iceland, Reykjavik, Iceland.
Division of Fixed Prosthodontics and Biomaterials, University Clinics for Dental Medicine, University of Geneva, Geneva, Switzerland.
Clin Oral Implants Res. 2021 Oct;32 Suppl 21(Suppl 21):254-288. doi: 10.1111/clr.13863.
To assess the survival, failure, and complication rates of veneered and monolithic all-ceramic implant-supported single crowns (SCs).
Literature search was conducted in Medline (PubMed), Embase, and Cochrane Central Register of Controlled Trials until September 2020 for randomized, prospective, and retrospective clinical trials with follow-up time of at least 1 year, evaluating the outcome of veneered and/or monolithic all-ceramic SCs supported by titanium dental implants. Survival and complication rates were analyzed using robust Poisson's regression models.
Forty-nine RCTs and prospective studies reporting on 57 material cohorts were included. Meta-analysis of the included studies indicated an estimated 3-year survival rate of veneered-reinforced glass-ceramic implant-supported SCs of 97.6% (95% CI: 87.0%-99.6%). The estimated 3-year survival rates were 97.0% (95% CI: 94.0%-98.5%) for monolithic-reinforced glass-ceramic implant SCs, 96.9% (95% CI: 93.4%-98.6%) for veneered densely sintered alumina SCs, 96.3% (95% CI: 93.9%-97.7%) for veneered zirconia SCs, 96.1% (95% CI: 93.4%-97.8%) for monolithic zirconia SCs and only 36.3% (95% CI: 0.04%-87.7%) for resin-matrix-ceramic (RMC) SCs. With the exception of RMC SCs (p < 0.0001), the differences in survival rates between the materials did not reach statistical significance. Veneered SCs showed significantly (p = 0.017) higher annual ceramic chipping rates (1.65%) compared with monolithic SCs (0.39%). The location of the SCs, anterior vs. posterior, did not influence survival and chipping rates.
With the exception of RMC SCs, veneered and monolithic implant-supported ceramic SCs showed favorable short-term survival and complication rates. Significantly higher rates for ceramic chipping, however, were reported for veneered compared with monolithic ceramic SCs.
评估饰面和整体式全陶瓷种植体支持的单冠(SC)的存活率、失败率和并发症发生率。
在 Medline(PubMed)、Embase 和 Cochrane 对照试验中心注册数据库中进行文献检索,检索时间截至 2020 年 9 月,检索内容为随访时间至少 1 年的评估饰面和/或整体式全陶瓷 SC 种植体支持的随机、前瞻性和回顾性临床试验。使用稳健泊松回归模型分析存活率和并发症发生率。
共纳入 49 项 RCT 和前瞻性研究,涉及 57 个材料组。对纳入研究的荟萃分析表明,饰面增强玻璃陶瓷种植体支持的 SC 的 3 年估计存活率为 97.6%(95%CI:87.0%-99.6%)。整体增强玻璃陶瓷种植体 SC 的 3 年估计存活率为 97.0%(95%CI:94.0%-98.5%),饰面致密烧结氧化铝 SC 为 96.3%(95%CI:93.9%-97.7%),饰面氧化锆 SC 为 96.1%(95%CI:93.4%-97.8%),整体氧化锆 SC 为 96.9%(95%CI:93.4%-98.6%),而树脂基质陶瓷(RMC)SC 仅为 36.3%(95%CI:0.04%-87.7%)。除 RMC SC 外(p < 0.0001),不同材料的存活率差异无统计学意义。饰面 SC 的陶瓷崩瓷年发生率(1.65%)明显高于整体 SC(0.39%)(p = 0.017)。SC 的位置(前牙或后牙)并不影响存活率和崩瓷率。
除 RMC SC 外,饰面和整体式种植体支持的陶瓷 SC 具有良好的短期存活率和并发症发生率。然而,与整体式陶瓷 SC 相比,饰面式陶瓷 SC 的陶瓷崩瓷率明显更高。